t(8;21)
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Dasatinib Combined With Chemotherapy in Relapsed t(8;21) Acute Myeloid Leukemia With KIT D816 Mutation (NCT03560908) | Institute of Hematology & Blood Diseases Hospital, China | 2018-07-01 |
| Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome (NCT00801489) | M.D. Anderson Cancer Center | 2007-04-04 |
Track t(8;21) automatically
Every clearance here is in the API, with alerts when new ones post.